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observed after 3 years (r = -0.34, p = 0.003 and r = -0.30, p= 0.01, 
respectively). In the lowest quartile of baseline mean JSW (< 4.5 
mm), the JSW even increased by 3.8 % (23.8) after 3-year in the 
placebo group and 6.2% (17.5) in the glucosamine sulfate group, 
although the difference between the two groups in these severe 
case was not statistically significant (p= 0.70). In the highest 
quartile of baseline mean JSW (> 6.2 mm), a joint space narrow- 
ing of 14.9 % (17.9) occurred in the placebo group while patients 
from the gtucosamine sulfate group only observed a narrowing of 
6.0 00 (15.1) after 3-years. Patients with the most severe OA at 
baseline had a RR of 0.42 (0.17 - 1.01) to experience a 0.5 mm 
joint space narrowing over 3 years, compared to those with the 
less affected joint. Glucosamine sulfate effect on joint space nar- 
rowing was borderline significant (p = 0.10) in the patients with 
mild OA in the highest quartile of baseline mean JSW. 
Conclusion: These results suggest that patients with the less 
severe radiographic signs of knee osteoarthritis will experience, 
over 3 years, the most dramatic disease progression in terms of 
joint space narrowing. Glucosamine sulfate appears to be partic- 
ularly beneficial in such patients, by reducing the rate of joint 
space narrowing by 55%. 
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Malate, MM 
Introduction: Osteoarthritis is the most common of all joint dis- 
eases, causing significant economic burden, much of which are 
data from western and developed countries. In the Philippines, 
urban data and anecdotal reports point to a high prevalence of 
osteoarthritis locally. With the projected population of the 
Philippines this year at 76 million, an estimated 3.1 million 
Filipinos will be suffering from osteoarthritis, based on the COP- 
CORD-ILAR study prevalence of 4.1%. In a large public tertiary 
hospital like UP-PGH, medical services are free but direct and 
indirect costs to both patients and government is unquantified. 
Results of economic burden analysis like this aims to improve the 
quality of clinical and financial decision making on the part of 
health planners and treating physicians by providing information 
on the overall cost of treatment. This is a preliminary report. 
Objectives: This paper seeks to quantify prospectively the 
direct and indirect costs associated with the care of uncompli- 
cated osteoarthritis in the University of the Philippines-- 
Philippine General Hospital Out Patient Arthritis Clinic, looking 
into its effects on the patient and society. 
Methods: A standard questionnaire was designed to include clin- 
ical data and the direct and indirect costs incurred by patients. A 
model was constructed based on Rheumatology consultants and 
Rheumatology fellows in training manning the clinic. The patient 
perspective included costs that were borne by the family includ- 
ing personal non-medical costs and productivity costs. All costs 
were expressed in Philippine peso, which is 50 pesos to a US dol- 
lar. 
Results: An assumption was made that 401,800 people with 
osteoarthritis from the National Capital Region (total population of 
9.8 million) will be seen per year in our clinics. The estimated total 
annual direct and indirect cost of treating an individual patient 
with osteoarthritis is P 8,278.00 or P 3,400,847, 919.23 for the 
National Capital Region. The cost of drugs contributed the 
largest, comprising 71% of the total annual cost. Laboratory 
examinations amounted to P 526,358,000.00 or about 15% of the 
total annual cost. Among the indirect costs, lost wages amount- 
ed to P 301,350,000.00 or about 8.8 %. 
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CLINICAL EFFECTS AND POSSIBLE MECHANISMS OF GLU- 
COSAMINE IN THE TREATMENT OF OSTEOARTHRITIS 
H Nakamura, K Masuko-Hongo, T Kato, K Nishioka 
Institute of Medical Science, St Marianna University, Kawasaki, 
Japan 
Aim: Glucosamine has been used for arthritis as a supplement. 
Many clinical studies have shown that glucosamine was effective 
for treatment of OA. Some in vitro experiments using chondro- 
cytes were reported; however the mechanism is still unclear. The 
objective of this study is to ascertain the efficacy of glucosamine 
on OA and elucidate its mechanism. 
Method: (1) Clinical study; 40 OA patients with 62 knees were 
administered with glucosamine preparation (1500mg/day) after 
informed consent. Knee score, VAS, Face scale and clinical 
symptoms were assessed for 3 months. Age matched 15 OA 
patients with 25 knees were used for control. Serum sample was 
collected before and after the treatment. The concentration of 
YKL-40, PGE2, NO and titer of anti type II collagen antibody 
(COLllab) were mesured in serum. (2)In vitro study: PGE2, NO, 
MMP-1, 3, 13 and TIMP-1 concentrations were detected in the 
supernatant of IL-1 stimulated human chondrocytes. 
Results: Knee score, VAS, Face scale as well as clinical symp- 
toms improved after the administration of glucosamine, while no 
improvement was found in the control group. Serum PGE2 con- 
centrations and titer of anti COLIlab decreased after the treat- 
ment. Serum YKL-40 concentrations showed no difference, how- 
ever, strong relationship was found between YKI40 and the stage 
of OA. In in vitro studies, glucosamine suppressed the production 
of PGE2, NO and MMP-1 in a dose dependent manner. 
Conclusion: Glucosamine preparation was effective for OA treat- 
ment clinically and the possible mechanism was suggested to be 
anti-inflammatory, immune modifying and chondroprotective 
effects. 
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Aim: An impingement mechanism between the anterior femoral 
head/neck junction and the acetabular im is hypothesized as a 
cause for early osteoarthritic hanges in young adults. This 
mechanism is thought to initiate cartilage lesions on the femoral 
head outside the main weightbearing area by mechanical force. 
We have examined the impinged tissue from the femoral 
head/neck junction histologically and then characterized it on a 
molecular basis. To understand the pathogenesis of this tissue, it 
was compared with healthy and to osteoarthritic artilage and 
examined for signs of osteoarthritis. 
Methods: Impinged (n=14) and osteoarthritic (n=9) cartilage 
biopsies were obtained intraoperatively, healthy cartilage from 
age matched deceased persons (n=6). All tissue samples were 
fixed in paraformaldehyde, decalcified in EDTA, and embedded in 
paraffin. 
Results: Histology according to Mankin criteria revealed signifi- 
cant differences between impinged and healthy cartilage, sug- 
gestive of degenerative changes. By immunohistology increased 
levels of COMP and tenascin, two proteins known to be upregu- 
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lated under pressure and tension, were found in impinged tis- 
sues. Transcripts encoding collagen I and I1 were detected by in 
situ hybridisation in hyaline cartilage. Transcript levels and distri- 
bution differed between the impinged tissue and the healthy car- 
tilage, Collagen II was upregulated as it is the case in early stages 
of osteoarthritis. 
Conclusions: The data suggest that the impinged tissue at the 
joint periphery shows characteristics of degeneration similar to 
those seen in osteoarthritic artilage. Therefore, impingement 
appears to cause local degenerative changes consistent with 
early osteoarthritis. It remains to be determined if these local 
lesions will lead to a generalized osteoarthritis of the hip. 
PB7 
MULTlSlTE VALIDATION STUDY OF THE WOMAC 3.1 LK QA 
INDEX USING A COMPUTERIZED TOUCHSCREEN 
VERSION IN A PHASE IV ROFECOXlB TRIAL 
Thei!er R. Bellamy N*, Kroesen S, Uebelhart D 
Depts of Physical Medicine and Rehabilitation, Cantonal 
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Centre of National Research on Disability and Rehabilitation 
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Aim: To Validate an electronic version of the WOMAC QA Index 
version 3.1 .LK for EDC use. 
Method: The Western Ontario and McMaster Universities 
(WOMAC) Osteoarthritis Index records with 24 questions the 
three dimensions for pain (5 questions), stiffness (2 questions) 
and function (17 questions) in patients suffering from hip or knee 
osteoarthritis (OA). This index is globally used in clinical OA trials. 
Electronic data capturing (EDC) is starting to be validated in clin- 
ical trials. 
At 10 study sites, 100 patients were included in a phase IV trial 
with rofecoxib, with radiographically proven OA completed the 
paper and computerized format over an interval of 15 minutes. 
The patients treated for 3 weeks with OA flares had to complete 
the paper and the electronic WOMAC questionnaire 3 times at 
each visit (visit 0/1/3).  The results of the computer- and paper- 
format were compared by intraclass correlation and Spearman's 
correlation coefficient. 
Results: The intraclass correlation coefficients for pain, stiffness 
and function values were 0.915, 0.745 and 0.940 respectively. 
The Spearman correlation coefficients for pain, stiffness and 
function were 0.88, 0.77 and 0.87 respectively. 
Conclusion: These data indicate that the computerized version 
of the WOMAC OA index 3.1 LK could be a valid and feasible 
instrument for EDC outcome measurement in osteoarthritis clini- 
cal trials and daily clinical routine. 
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WITH INCIDENT OSTEOARTHRITIS (OA) 
OF THE KNEE: DATA FROM THE BALTIMORE 
LONGITUDINAL STUDY OF AGING (BLSA) 
Shari M Ling. Margaret Lethbridge-Cejku, 
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Aim: To examine the association of body fatness, body composi- 
tion and body weight,with incident OA of the knee. 
Methods: Secondary analyses were conducted on longitudinal 
dual photon absorptiometry (DPA) data acquired from 156 men 
and 104 women BLSA participants who had no knee OA on bilat- 
eral standing knee radiographs between 1984 and 1991. Incident 
knee OA was defined as Keltgren-Lawrence grade 2 or higher of 
the more s~verely affected knee on a follow-up radiograph per- 
formed between 1994 and 1996. Body mass index (BMI) was 
assessed by examination, and fat and muscle mass by DPA. 
ANCOVA with mixed-effects modeling was used to analyze the 
data acquired from 593 DPA scans performed on these 260 sub- 
jects a mean of t.25 ± 2.9 years prior to the second radiograph. 
Results: 
Adjusted means ± SE 
Age (yrs) at time of initial 
radiograph 
Gender 
BMI (kg/cm 2) 
% Fatness ([g]/weight[g] 
x100) 
% Fat ([g]/ muscle [g] 
x 100) 
Incident knee OA No knee OA 
(n=42) (n=218) 
63.2 ± 1.9 54.4 ± 0.9 
21men 135men 
21women 83women 
27.3±0.3 26.5±0.3 
36.4±0.9 34.5±0.9 
60.4±1.5 57.3±1.4 
After adjustment for BMI, age, gender and time, the fat to body 
weight ratio was higher in subjects with incident knee OA than 
subjects without incident knee OA (p=0.04). Incident knee OA 
subjects also had a higher fat to muscle mass ratio than subjects 
without incident knee OA (p=0.04). 
Conclusion: These results show that fatness and higher fat to 
muscle mass ratio are independently associated with the devel- 
opment of incident knee OA. This association appears to be inde- 
pendent of BMI. 
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LOWER EXTREMITY OSTEOARTHRITIS (OA) INCREASES 
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Aim: This study was conducted to estimate the impact of lower 
extremity OA upon transition of mobility function over 36 months, 
and to evaluate the contributions of strength and weight to these 
transitions. 
Methods: Secondary analyses were conducted of longitudinal 
data acquired for the Women's Health and Aging Study II, a 
prospective, population-based study designed to elucidate the 
transition from pre-clinical to clinical disability in community- 
residing older women. In this cohort exclusive of women with 
rheumatoid arthritis and heart disease, 22 women were classified 
as having knee and hip OA, 80 with knee OA, 7 with hip OA, and 
208 with neither knee nor hip OA at baseline using clinical algo- 
rithms modeled on the ACR criteria. Transitions to new clinical 
mobility disability was assessed at the 18 and 36-month follow- 
up by self-report of difficulty with aerobic tasks (walking a half- 
mile or climbing stairs), non-aerobic tasks (bending, stooping or 
transferring into or out of a car or bus), or combined (aerobic and 
non-aerobic task difficulty reported). Baseline demographic har- 
acteristics, strength and weight of women with lower extremity 
OA were compared to those with no lower extremity OA using 
ANOVA, and entered into logistic regression models to determine 
the odds of transitions to additional disability categories over 36 
months. 
Results: Lower extremity OA was associated with a 7.42 greater 
risk (p =0.003) for aerobic mobility tasks, and 2.48 greater isk of 
transition to combined aerobic and non-aerobic task difficulty (p 
= 0.013). Women with lower extremity OA had lower baseline 
weight-adjusted knee extensor strength (0.269 kg/kg weight) and 
